1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61191F1B1E70E3B618525830E00506636
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/driving-the-value-of-digital-initiatives-in-medical-affairs-channel-activities-and-challenges?opendocument
18
19opendocument
2054.81.69.220
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Communication

Driving the Value of Digital Initiatives in Medical Affairs: Channel Activities and Challenges

ID: 5525


Features:

11 Info Graphics

13 Data Graphics

250+ Metrics


Pages/Slides: 34


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Driving the Value of Digital Initiatives in Medical Affairs: Channel Activities and Challenges"

STUDY OVERVIEW


Digitalization is changing the way Medical Affairs interacts with key internal and external stakeholders. Virtual communication, mobile apps, data analytics tools, interactive platforms and medical booths are some examples of how the digital world is playing an evolving role in Medical Affairs. But as pharmaceutical companies increasingly turn to digital tools for Medical Affairs activities, some organizations are struggling with the speed of digitalization, and where to focus digital efforts within Medical Affairs.

Best Practices, LLC undertook this benchmarking research to provide insights into the digital activities and channels being used and explored by Medical Affairs groups, and the challenges that come with digitalization. Medical Affairs leaders can use this study to compare their digital activities and strategies with industry peers.

This study provides three segments: all participating companies, digitally mature companies and digitally evolving companies.

KEY TOPICS

  • Digital Landscape
  • Digital Capabilities

KEY METRICS

  • What is your digital maturity level across: digital planning, digital resources, leadership support and capabilities
  • Which group(s) does your medical affairs group serve through digital channels
  • How important and effective are these groups to your medical affairs group's digital initiative plans
  • How active is your medical affairs function in building/offering each of the following digital capabilities
  • What key activities currently done off-line does your medical affairs group plan on digitizing
  • Effectiveness of following e-medical channels in increasing overall engagement
  • Top challenges of using digital channels versus non-digital for engaging external stakeholders

SAMPLE KEY FINDINGS

  • Most Effective Digital Channels: Virtual Ad Boards for digital interactions, medical education programs for online programs, and web services for unbranded websites and self-service portals were channels rated most effective by 77%, 74% and 70% of respondents, respectively.

METHODOLOGY

This study engaged 68 participants From 35 Companies with experience in medical affairs digital activities at top pharmaceutical companies.


Industries Profiled:
Pharmaceutical; Health Care; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Clinical Research; Laboratories; Communications


Companies Profiled:
Novartis; Boehringer Ingelheim; AstraZeneca; Merck; GlaxoSmithKline ; Bayer; Allergan; Abbott; EMD Serono; GE Healthcare; Sanofi; Roche; Pfizer; Shire; Novo Nordisk; MSD; Astellas; Santen; Jazz Pharmaceuticals; Eisai; Sanofi Pasteur; Vifor Pharma; Alkermes; Sanofi Genzyme; Sunovion; ViiV Healthcare; Sage Therapeutics; Seqirus; Incyte; Chiesi; Heron Therapeutics; Ipsen; Ferring Pharmaceuticals; ApotheCom; Indegene

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.